Drugs Approved for Stomach (Gastric) Cancer - National Cancer Institute

Drugs Approved for Stomach (Gastric) Cancer - National Cancer Institute

Drugs Approved for Stomach (Gastric) Cancer

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for stomach (gastric) cancer. The list includes generic and brand names. This page also lists common drug combinations used in stomach (gastric) cancer. The individual drugs in the combinations are FDA-approved. However, the drug combinations themselves usually are not approved, although they are widely used.

The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in stomach (gastric) cancer that are not listed here.

ON THIS PAGE

• Drugs Approved for Stomach (Gastric) Cancer
• Drug Combinations Used in Stomach (Gastric) Cancer
• Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors

Drugs Approved for Stomach (Gastric) Cancer

• Cyramza (Ramucirumab)
• Docetaxel
• Doxorubicin Hydrochloride
• 5-FU (Fluorouracil Injection)
• Fluorouracil Injection
• Herceptin (Trastuzumab)
• Keytruda (Pembrolizumab)
• Mitomycin C
• Pembrolizumab
• Ramucirumab
• Taxotere (Docetaxel)
• Trastuzumab

Drug Combinations Used in Stomach (Gastric) Cancer

• FU-LV
• TPF
• XELIRI

Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors

• Afinitor (Everolimus)
• Everolimus
• Lanreotide Acetate
• Somatuline Depot (Lanreotide Acetate)

Related Resources

• Stomach (Gastric) Cancer—Patient Version
• Chemotherapy and You: Support for People With Cancer

• Updated: August 15, 2018